Company / EPS (Diluted)
AIM ImmunoTech Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$30.92
FY2025
5-year range
-$30.92 / -$0.40
FY2021-FY2025
Trend
-5053.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -5053% YoY in FY2025, a notable deviation from the 8-year average annual change of -1014%.
Based on SEC 10-K filings.
-30.92 in FY2025.
Declined from $-0.40 to $-30.92 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 5053.3% year-over-year.
- Peak eps (diluted) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$30.92 | -5053.3% |
| FY2024 | -$0.60 | -50.0% |
| FY2023 | -$0.40 | - |
| FY2022 | - | - |
| FY2021 | -$0.45 | +82.6% |
| FY2020 | -$2.58 | +73.6% |
| FY2019 | -$9.77 | -3269.0% |
| FY2018 | -$0.29 | +62.3% |
| FY2017 | -$0.77 | +30.6% |
| FY2016 | -$1.11 | -1010.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026